Kimberly-Clark Corporation

🇺🇸New York Stock Exchange
Back to all articles
Kimberly-Clark Corporation stock analysis KMB overview
Somewhat Bullish +50

Kimberly-Clark Q1 Earnings Beat Estimates, Sales Up 2.7% Y/Y

📅 Kimberly-Clark Corporation reported first-quarter 2026 results on April 28, 2026, beating analyst estimates for both revenue and earnings.

💰 Adjusted earnings per share reached $1.97, surpassing the consensus estimate of $1.92 and representing a 2.1% increase over the prior year.

📈 Total sales climbed to $4.163 billion, marking a 2.7% year-over-year rise that exceeded the expected $4.106 billion.

🌍 The revenue growth was driven by a 2.5% organic increase and currency benefits, though partly offset by exiting the U.S. private label diaper business.

📉 Adjusted gross margins fell 60 basis points to 37.9% due to unfavorable pricing relative to cost inflation and ongoing supply-chain investments.

💸 Operating profit in North America declined 8.1% to $623 million, primarily due to a significant headwind from business exits and higher advertising spend.

🚀 International Personal Care sales surged 9.1% and operating profit jumped 21.9%, driven by volume growth and productivity savings.

💧 The company ended the quarter with $542 million in cash, while capital spending totaled $424 million and dividends returned $418 million to shareholders.

📉 For 2026, management expects organic sales growth to match or slightly outpace the weighted average of its categories and markets.

📊 Adjusted operating profit is projected to grow at a mid to high-single-digit rate on a constant-currency basis throughout the year.

🧬 Adjusted EPS from continuing operations is expected to rise double-digit, though total diluted EPS is anticipated to remain flat due to discontinued operations income dropping.

⚠️ Analysts expect continued earnings impact from the closing of the IFP transaction in mid-2026, which will fund part of the Kenvue acquisition.

📉 The stock has lost 1.3% over the past three months, underperforming slightly compared to the industry's larger 2.9% decline.

🤖 This summary was generated based on Zacks Consensus data and Q1 financial results provided for Kimberly-Clark Corporation.

💡 Readers seeking alternative investment ideas may consider competitors like Post Holdings or Tyson Foods currently rated Buy by analysts.

Bullish Signals
  • Kimberly-Clark Corporation (KMB) beat analyst estimates with adjusted earnings of $1.97 per share, surpassing the consensus expectation of $1.92.
  • Total sales increased 2.7% year-over-year to $4,163 million, driven by a 3% volume increase and strong innovation in the consumer markets.
  • The International Personal Care (IPC) segment delivered exceptional performance with net sales jumping 9.1% and operating profit surging 21.9% to $245 million.
  • Organic sales growth was supported by a 4.1% increase in volume and improved product mix, reflecting strong consumer value propositions.
  • Cash flow remained robust with $745 million provided by operations for the quarter while capital spending totaled $424 million.
  • Management forecasts that adjusted EPS from continuing operations will grow at a double-digit rate in 2026.
  • The company expects mid-to-high single-digit growth in adjusted operating profit on a constant-currency basis for the full year.
  • KMB outperformed the broader industry, falling only 1.3% over the past three months compared to the sector's 2.9% decline.
Risk Factors
  • North America segment operating profit fell 8.1% to $623 million due to a 490-basis-point headwind from business exits and increased advertising spend.
  • Adjusted gross margin contracted by 60 basis points to 37.9% as productivity gains were outweighed by unfavorable pricing relative to cost inflation and continued supply-chain investments.
  • Pricing declined 0.5% in the U.S. as the company invested in product trials and value positioning, negatively impacting revenue growth.
  • North America net sales decreased 0.6% year over year driven by a 2.7% decline from exiting the U.S. private label diaper business.
  • Adjusted EPS attributable to Kimberly-Clark is expected to remain flat on a constant-currency basis due to lower income from discontinued operations.
  • The company expects a roughly 50-basis-point headwind in future net sales projections stemming from the exit of the U.S. private label diaper business.
  • Kimberly-Clark's stock has lost 1.3% over the past three months, though this performance is better than the industry's 2.9% decline, it still indicates downward pressure.
  • Management incurred significant capital spending of $424 million in Q1, which may constrain cash flow available for other operational investments or shareholder returns.
Full Analysis
Kimberly-Clark Corporation (KMB) reported first-quarter 2026 results that exceeded analyst expectations for both sales and earnings. Adjusted earnings per share reached $1.97, surpassing the Zacks Consensus Estimate of $1.92, representing a 2.1% year-over-year increase driven by higher adjusted operating profit and income from discontinued operations. Total net sales rose to $4,163 million, a 2.7% increase from the prior year's $4,054 million, which beat the consensus estimate of $4,106 million. This growth was fueled by organic expansion of 2.5% and favorable currency effects of 2%, though partially offset by an 1.8% decline resulting from exiting the U.S. private label diaper business. Volume and mix contributed a 3% increase to sales, while pricing decreased by 0.5% due to investments in product trials and value positioning. Geographically, performance varied significantly between domestic and international segments. In North America, net sales declined 0.6% year over year to $2,651 million, primarily impacted by the 2.7% revenue loss from closing the private label diaper division; however, underlying organic sales still grew 1.8% due to volume gains. Operating profit in this region fell 8.1% to $623 million amid a substantial 490-basis-point headwind from the business exit and increased advertising spend, though productivity savings provided some relief. Conversely, the International Personal Care segment saw robust growth with net sales jumping 9.1% to $1,512 million, driven by organic volume increases of 4.1% and mix improvements of 1.4%. Operating profit in this segment surged 21.9% to $245 million as benefits from currency, lower overhead costs, and productivity gains outweighed negative pricing pressures from strategic investments. The company's financial health remains stable with cash and cash equivalents of $542 million, long-term debt at $6,475 million, and total stockholders' equity of $1,914 million. During the quarter, cash provided by operations was $745 million, while capital spending amounted to $424 million; shareholder returns included $418 million in dividends. Looking ahead to fiscal 2026, management forecasts organic sales growth in line with or slightly ahead of category averages, which grew approximately 2.5% over the past year. Financial guidance anticipates adjusted operating profit to grow at a mid-to-high-single-digit rate on a constant-currency basis, while adjusted EPS from continuing operations is expected to rise double-digit-wise despite a flat overall attributable EPS due to lower income from discontinued operations associated with the anticipated closing of the IFP transaction in mid-2026.